2011 Biosecurity Breakout Sessions
(with confirmed speakers as of June 15, 2011)
Speaking Companies and Organizations Include:
- 21CB
- Achaogen
- American Association for the Advancement of Science (AAAS)
- Biomedical Advanced Research and Development Authority (BARDA)
- Biotechnology Industry Organization
- BWC Review Conference
- Center for Biosecurity at UPMC
- Center for Emergency Preparedness and Response, Public Health Canada
- Centers for Disease Control and Prevention
- Defense Threat Reduction Agency
- George Washington University
- Henry L. Stimson Center
- Illinois Science and Technology Coalition
- In-Q-Tel
- Institute for Strategic Threat Analysis and Response, University of Pennsylvania
- ISTAR
- Life Technologies
- MPM Capital
- National Commission on Children and Disasters
- National Eczema Association
- National Security Council
- Pacific Northwest National Laboratory
- PharmAthene
- PRTM Management Consultants
- Sandia National Laboratories
- SIGA Technologies
- Tahoe Research Initiative
- U.S. Department of Agriculture
- U.S. Department of Defense
- U.S. Department of Health and Human Services
- U.S. Department of Homeland Security
- WMD Commission
- Woodrow Wilson International Center for Scholars
- XOMA
Agenda
Wednesday June 29, 2011
8:30 am – 9:45 am
A View from the Hill
Introductory Comments, Jim Greenwood, President, Biotechnology Industry Organization
Senator Richard Burr (R-N.C.), Member, Senate Health, Education, Labor and Pensions, Armed Services, and Intelligence committees
Jim Talent, Senator; Co-Chair, WMD Commission
Theresa Tam, Director General, Center for Emergency Preparedness and Response, Public Health Canada
Tom Inglesby, Center for Biosecurity at UPMC
• Discuss Congressional views on domestic biodefense and international biosecurity initiatives.
• Review policy approaches to funding, implementing, and evaluating key biodefense and biosecurity programs.
• Evaluate needed policy initiatives to promote and prioritize global biosecurity.
10:00 am – 11:30 am
Improving Global Bio-surveillance
Ben Petro, Department of Defense (Moderator)
Pamela Diaz, Director for Biosurveillance Coordination, CDC
Kim Green, Director of Food Defense Staff, USDA
Rebecca Katz, George Washington University
Evan Skowronski, Tahoe Research Initiative
• Examine efforts to improve bio-surveillance efforts around the world.
• Discuss roles in implementing bio-surveillance programs and integrating them with established global surveillance networks.
• Review bio-surveillance activities in the zoonotic, food, and agricultural sectors.
12:00 pm - 2:00 pm
BIO Keynote Luncheon
Open to Biosecurity Conference Attendees
2:00 pm - 3:30 pm
Managing Global Challenges in an Evolving Threat Environment
Sponsored by: Sandia National Laboratories
Gerald Epstein, Director of The Center for Science, Technology, and Security Policy, AAAS (Moderator)
Reynolds Salerno, Sandia National Laboratories
Eric Rose, President and Chief Executive Officer, SIGA Technologies, Inc.
Alexander Garza, Assistant Secretary for Health Affairs, Department of Homeland Security
Matthew Botos, Illinois Science and Technology Coalition
• Review the multiple challenges facing the implementation of global biosecurity practices.
• Examine efforts to assess the threats facing different regions.
• Describe approaches to the standardization of regulations, improving coordination of transportation, dispensing, and delivery across borders.
3:45 pm – 5:00 pm
Successes and Challenges in Public-Private Partnerships
Pat Scannon, XOMA (Moderator)
Robin Robinson, Director, BARDA
Gerald Parker, Deputy Assistant Secretary of Defense for Chemical and Biological Defense
John Hollway, Achaogen
• Review successful public-private partnerships’ management of complex arrangements or issues such as IP, legal issues, manufacturing responsibilities.
• Highlight experiences implementing a complex, multi-site, multi-product research and manufacturing enterprise.
• Discuss potential solutions that will help lead to success.
Thursday, June 30, 2011
8:30 am - 9:45 am
Financing Biodefense as a National Security Priority
Robert Kadlec, PRTM Management Consultants (Moderator)
Chris Darby, President and Chief Executive Officer, In-Q-Tel
Eric I. Richman, President and Chief Executive Officer, PharmAthene, Inc.
Richard Hatchett, HHS-ASPR
Randall Larsen, WMD Center
Steven St. Peter, MPM Capital
• Review existing methods for funding the countermeasures enterprise, including new initiatives to stimulate increased private sector involvement.
• Evaluate the criteria used by private capital firms to assess new technologies and products.
• Discuss ways that industry, government and equity firms can work together and what milestones would be appropriate in the countermeasures arena.
10:00 am – 11:30 am
Protecting the Unprotected: Countermeasures for At-Risk and Vulnerable Populations
Sponsored by: Bavarian Nordic
Chris Colwell, Public Policy Strategy, Becton, Dickinson, and Company (Moderator)
Nicki Pesik, CDC
Sue Chibulski, HHS-ASPR
Gregg Lord, Commissioner, National Commission on Children and Disasters
Julie Block, President and Chief Executive Officer, National Eczema Association
• Detail the unmet need for medical countermeasures to protect all individuals.
• Evaluate past efforts to protect at-risk and vulnerable populations.
• Discuss approaches to integrating vulnerable populations into medical countermeasures planning, development, and dispensing.
Chris Colwell, Public Policy Strategy, Becton, Dickinson, and Company (Moderator)
11:30 am -- 1:00 pm
Managing Technological Innovation in the New Era
Sponsored by: National Nuclear Security Administration
Harvey Rubin, Director, ISTAR, University of Pennsylvania (Moderator)
Alan Rudolph, Director, Chemical-Biological Technologies Directorate
Antonietta Gatti, Italian Institute of Technology Project on Nanoecotoxicology
Todd Peterson, Life Technologies
Cindy Bruckner-Lea, Pacific Northwest National Laboratory
• Discuss the latest technologies, such as synthetic biology and nanotechnology, and their importance for facing new natural and man-made threats.
• Describe how technological innovation can be used help prevent, identify or respond to emerging diseases.
• Evaluate how technological innovation may be used by rogue nations or select groups.
1:30 pm – 2:00 pm
Closing Keynote Address: “The Role of the BWC in a Biotech-Driven World,”
Keynote Speaker: Ambassador Paul van den Ijssel, President of the 2011 BWC Review Conference
• Explain the relevance of the 2011 BWC Review Conference to multiple constituencies.
• Discuss ways the BWC annual meeting process can enhance global biosecurity
• Evaluate the Review Conference’s response to new and emerging technological threats
View Complete Agenda